Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Granuloma, Plasma Cell × ceritinib × 1 year × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 2 Neoplasms 2 Lung Neoplasms 2 Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1

Interventions

pazopanib 2 Ifosfamide 2 Doxorubicin 2 selinexor 1 repotrectinib 1 ceritinib 1 brigatinib 1 Suspensions 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Crizotinib 1 Capsules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05100134 2025-12-09

Managed Access Programs for LDK378, Ceritinib

Novartis

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡